Intellia has reported results from a phase 2 trial of its gene-editing drug for hereditary angioedema (HAE) that it says build the case for the drug as a phase 3 trial gets underway – but its shares ...

It will take years to transform business, but the journey begins now. by Marco Iansiti and Karim R. Lakhani Contracts, transactions, and the records of them are among the defining structures in our ...